Cutler Group LP Summit Therapeutics Inc. Call Options Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$2.55 - $5.07 $1,019 - $2,028	400 New	400 $0
Q2 2023 Jul 18, 2023	BUY	$1.32 - $2.81 $1,056 - $2,248	800 Added 80.0%	1,800 $2,000
Q1 2023 May 01, 2023	BUY	$1.38 - $5.41 $1,242 - $4,869	900 Added 900.0%	1,000 $0
Q3 2022 Oct 25, 2022	BUY	$0.89 - $1.63 $89 - $163	100 New	100 $0
Q3 2021 Oct 26, 2021	BUY	$4.83 - $8.27 $11,592 - $19,848	2,400 New	2,400 $0

193

75.8M

2.01M

2.84M

Ticker SMMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,215,008
Market Cap $3.82B
Description
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.